M-CAT element mediates mechanical stretch-activated transcription of B-type natriuretic peptide via ERK activation

Canadian Journal of Physiology and Pharmacology

Volumn 89, Issue 8, 2011, Pages 539-550

  Koivisto, Elina ^a   Karkkola, Laura ^a   Majalahti, Theresa ^a   Aro, Jani ^a   Tokola, Heikki ^a   Kerkelä, Risto ^a   Ruskoaho, Heikki ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Cardiac hypertrophy; Gene expression; Mechanical stretch; Mitogen activated protein kinases; Myocyte enhancer factor 2; Natriuretic peptides; Transcription factors; Transcriptional enhancer factor 1

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; ENZYME ACTIVATION; EVOKED MUSCLE RESPONSE; GENE MUTATION; GENETIC TRANSCRIPTION; HEART MUSCLE CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MUSCLE CAT ELEMEMT; MUSCLE STRETCHING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT;

ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELLS, CULTURED; DNA-BINDING PROTEINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HYPERTROPHY; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MUSCLE PROTEINS; MUTATION; MYOCARDIUM; MYOCYTES, CARDIAC; MYOGENIC REGULATORY FACTORS; NATRIURETIC PEPTIDE, BRAIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; REGULATORY ELEMENTS, TRANSCRIPTIONAL; TRANSCRIPTIONAL ACTIVATION;

EID: 79961194215     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/y11-049     Document Type: Article

References (54)

1. Akazawa, H., and Komuro, I. 2003. Roles of cardiac transcription factors in cardiac hypertrophy. Circ. Res. 92(10): 1079-1088. doi:10.1161/01.RES.0000072977.86706.23. PMID:12775656.
2. Belandia, B., and Parker, M.G. 2000. Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors. J. Biol. Chem. 275(40): 30801-30805. doi:10.1074/jbc.C000484200. PMID:10934189.
3. Bish, L.T., Morine, K.J., Sleeper, M.M., and Sweeney, H.L. 2010. Myostatin is upregulated following stress in an Erk-dependent manner and negatively regulates cardiomyocyte growth in culture and in a mouse model. PLoS ONE, 5(4): e10230. doi:10.1371/ journal.pone.0010230. PMID:20419100.
4. Carlini, L.E., Getz, M.J., Strauch, A.R., and Kelm, R.J., Jr. 2002. Cryptic MCAT enhancer regulation in fibroblasts and smooth muscle cells. Suppression of TEF-1 mediated activation by the single-stranded DNA-binding proteins, Pur alpha, Pur beta, and MSY1. J. Biol. Chem. 277(10): 8682-8692. doi:10.1074/jbc. M109754200. PMID:11751932.
5. Chen, Z., Friedrich, G.A., and Soriano, P. 1994. Transcriptional enhancer factor 1 disruption by a retroviral gene trap leads to heart defects and embryonic lethality in mice. Genes Dev. 8(19): 2293-2301. doi:10.1101/gad.8.19.2293. PMID:7958896.
6. Dagnino, L., Lavigne, J.P., and Nemer, M. 1992. Increased transcripts for B-type natriuretic peptide in spontaneously hypertensive rats. Quantitative polymerase chain reaction for atrial and brain natriuretic peptide transcripts. Hypertension, 20(5): 690-700. PMID:1385327.
7. Farrance, I.K., Mar, J.H., and Ordahl, C.P. 1992. M-CAT binding factor is related to the SV40 enhancer binding factor, TEF-1. J. Biol. Chem. 267(24): 17234-17240. PMID:1324927.
8. Gupta, M., Kogut, P., Davis, F.J., Belaguli, N.S., Schwartz, R.J., and Gupta, M.P. 2001. Physical interaction between the MADS box of serum response factor and the TEA/ATTS DNA-binding domain of transcription enhancer factor-1. J. Biol. Chem. 276(13): 10413- 10422. doi:10.1074/jbc.M008625200. PMID:11136726.
9. Hama, N., Itoh, H., Shirakami, G., Nakagawa, O., Suga, S., Ogawa, Y., et al. 1995. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation, 92(6): 1558-1564. PMID:7664440.
10. Hasegawa, K., Lee, S.J., Jobe, S.M., Markham, B.E., and Kitsis, R.N. 1997. Cis-Acting sequences that mediate induction of beta-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction. Circulation, 96(11): 3943-3953. PMID:9403619.
11. Hautala, N., Tokola, H., Luodonpaa, M., Puhakka, J., Romppanen, H., Vuolteenaho, O., and Ruskoaho, H. 2001. Pressure overload increases GATA4 binding activity via endothelin-1. Circulation, 103(5): 730-735. PMID:11156886.
12. He, Q., and LaPointe, M.C. 1999. Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes. Hypertension, 33(1 Pt 2): 283-289. PMID:9931118.
13. Heineke, J., and Molkentin, J.D. 2006. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell Biol. 7(8): 589-600. doi:10.1038/nrm1983. PMID:16936699.
14. Hill, J.A., and Olson, E.N. 2008. Cardiac plasticity. N. Engl. J. Med. 358(13): 1370-1380. doi:10.1056/NEJMra072139. PMID: 18367740.
15. Jessup, M., and Brozena, S. 2003. Heart failure. N. Engl. J. Med. 348(20): 2007-2018. doi:10.1056/NEJMra021498. PMID:12748317.
16. Kerkelä, R., Pikkarainen, S., Majalahti-Palviainen, T., Tokola, H., and Ruskoaho, H. 2002. Distinct roles of mitogen-activated protein kinase pathways in GATA-4 transcription factor-mediated regulation of B-type natriuretic peptide gene. J. Biol. Chem. 277(16): 13752-13760. doi:10.1074/jbc.M105736200. PMID:11827958.
17. Kerkelä, R., Woulfe, K., and Force, T. 2007. Glycogen synthase kinase-3beta-actively inhibiting hypertrophy. Trends Cardiovasc. Med. 17(3): 91-96. doi:10.1016/j.tcm.2007.01.004. PMID: 17418370.
18. Kinnunen, P., Vuolteenaho, O., and Ruskoaho, H. 1993. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology, 132(5): 1961-1970. doi:10.1210/en.132.5.1961. PMID:8477647.
19. LaPointe, M.C. 2005. Molecular regulation of the brain natriuretic peptide gene. Peptides, 26(6): 944-956. doi:10.1016/j.peptides. 2004.08.028. PMID:15911064.
20. LaPointe, M.C., Wu, G., Garami, M., Yang, X.P., and Gardner, D.G. 1996. Tissue-specific expression of the human brain natriuretic peptide gene in cardiac myocytes. Hypertension, 27(3 Pt 2): 715-722. PMID:8613230.
21. Larkin, S.B., Farrance, I.K., and Ordahl, C.P. 1996. Flanking sequences modulate the cell specificity of M-CAT elements. Mol. Cell. Biol. 16(7): 3742-3755. PMID:8668191.
22. Liang, F., and Gardner, D.G. 1999. Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism. J. Clin. Invest. 104(11): 1603-1612. doi:10.1172/JCI7362. PMID:10587524.
23. Liang, F., Wu, J., Garami, M., and Gardner, D.G. 1997. Mechanical strain increases expression of the brain natriuretic peptide gene in rat cardiac myocytes. J. Biol. Chem. 272(44): 28050-28056. doi:10.1074/jbc.272.44.28050. PMID:9346958.
24. Liang, F., Lu, S., and Gardner, D.G. 2000. Endothelin-dependent and -independent components of strain-activated brain natriuretic peptide gene transcription require extracellular signal regulated kinase and p38 mitogen-activated protein kinase. Hypertension, 35(1 Pt 2): 188-192. PMID:10642296.
25. Maeda, T., Chapman, D.L., and Stewart, A.F. 2002a. Mammalian vestigial-like 2, a cofactor of TEF-1 and MEF2 transcription factors that promotes skeletal muscle differentiation. J. Biol. Chem. 277(50): 48889-48898. doi:10.1074/jbc.M206858200. PMID:12376544.
26. Maeda, T., Gupta, M.P., and Stewart, A.F. 2002b. TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters. Biochem. Biophys. Res. Commun. 294(4): 791-797. doi:10.1016/ S0006-291X(02)00556-9. PMID:12061776.
27. Magga, J., Marttila, M., Mäntymaa, P., Vuolteenaho, O., and Ruskoaho, H. 1994. Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin- and phenylephrine-infused conscious rats. Endocrinology, 134(6): 2505-2515. doi:10.1210/en. 134.6.2505. PMID:8194476.
28. Majalahti-Palviainen, T., Hirvinen, M., Tervonen, V., Ilves, M., Ruskoaho, H., and Vuolteenaho, O. 2000. Gene structure of a new cardiac peptide hormone: a model for heart-specific gene expression. Endocrinology, 141(2): 731-740. doi:10.1210/en. 141.2.731. PMID:10650955.
29. Mäntymaa, P., Vuolteenaho, O., Marttila, M., and Ruskoaho, H. 1993. Atrial stretch induces rapid increase in brain natriuretic peptide but not in atrial natriuretic peptide gene expression in vitro. Endocrinology, 133(3): 1470-1473. doi:10.1210/en.133.3. 1470. PMID:8365376.
30. Mar, J.H., and Ordahl, C.P. 1988. A conserved CATTCCT motif is required for skeletal muscle-specific activity of the cardiac troponin T gene promoter. Proc. Natl. Acad. Sci. U.S.A. 85(17): 6404-6408. doi:10.1073/pnas.85.17.6404. PMID:3413104.
31. McLean, B.G., Lee, K.S., Simpson, P.C., and Farrance, I.K. 2003. Basal and alpha1-adrenergic-induced activity of minimal rat betaMHC promoters in cardiac myocytes requires multiple TEF-1 but not NFAT binding sites. J. Mol. Cell. Cardiol. 35(5): 461-471. doi:10.1016/S0022-2828(03)00049-X. PMID:12738228.
32. Ogawa, Y., Nakao, K., Mukoyama, M., Hosoda, K., Shirakami, G., Arai, H., et al. 1991. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ. Res. 69(2): 491-500. PMID:1830518.
33. Pikkarainen, S., Kerkelä, R., Pöntinen, J., Majalahti-Palviainen, T., Tokola, H., Eskelinen, S., et al. 2002. Decoy oligonucleotide characterization of GATA-4 transcription factor in hypertrophic agonist induced responses of cardiac myocytes. J. Mol. Med. 80(1): 51-60. doi:10.1007/s001090100278. PMID:11862325.
34. Pikkarainen, S., Tokola, H., Kerkela, R., Majalahti-Palviainen, T., Vuolteenaho, O., and Ruskoaho, H. 2003a. Endothelin-1-specific activation of B-type natriuretic peptide gene via p38 mitogen-activated protein kinase and nuclear ETS factors. J. Biol. Chem. 278(6): 3969-3975. doi:10.1074/jbc.M205616200. PMID:12446726.
35. Pikkarainen, S., Tokola, H., Majalahti-Palviainen, T., Kerkela, R., Hautala, N., Bhalla, S.S., et al. 2003b. GATA-4 is a nuclear mediator of mechanical stretch-activated hypertrophic program. J. Biol. Chem. 278(26): 23807-23816. doi:10.1074/jbc. M302719200. PMID:12704188.
36. Rockman, H.A., Ross, R.S., Harris, A.N., Knowlton, K.U., Steinhelper, M.E., Field, L.J., et al. 1991. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 88(18): 8277-8281. doi:10.1073/pnas.88. 18.8277. PMID:1832775.
37. Ruskoaho, H. 2003. Cardiac hormones as diagnostic tools in heart failure. Endocr. Rev. 24(3): 341-356. doi:10.1210/er.2003-0006. PMID:12788803.
38. Sadoshima, J., and Izumo, S. 1997. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu. Rev. Physiol. 59(1): 551-571. doi:10.1146/annurev.physiol.59.1.551. PMID:9074777.
39. Sadoshima, J., Jahn, L., Takahashi, T., Kulik, T.J., and Izumo, S. 1992. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. J. Biol. Chem. 267(15): 10551-10560. PMID:1534087.
40. Shubeita, H.E., McDonough, P.M., Harris, A.N., Knowlton, K.U., Glembotski, C.C., Brown, J.H., and Chien, K.R. 1990. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. J. Biol. Chem. 265(33): 20555-20562. PMID:2173712.
41. Stewart, A.F., Larkin, S.B., Farrance, I.K., Mar, J.H., Hall, D.E., and Ordahl, C.P. 1994. Muscle-enriched TEF-1 isoforms bind M-CAT elements from muscle-specific promoters and differentially activate transcription. J. Biol. Chem. 269(5): 3147-3150. PMID: 8106348.
42. Sugden, P.H., and Clerk, A. 1998. Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 76(11): 725-746. doi:10.1007/ s001090050275. PMID:9826118.
43. Takahashi, T., Allen, P.D., and Izumo, S. 1992. Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Correlation with expression of the Ca(2 +)-ATPase gene. Circ. Res. 71(1): 9-17. PMID:1535030.
44. Tavi, P., Laine, M., Weckstrom, M., and Ruskoaho, H. 2001. Cardiac mechanotransduction: from sensing to disease and treatment. Trends Pharmacol. Sci. 22(5): 254-260.
45. doi:10.1016/S0165-6147 (00)01679-5.
46. PMID:11339977.
47. Tenhunen, O., Sarman, B., Kerkela, R., Szokodi, I., Papp, L., Toth, M., and Ruskoaho, H. 2004. Mitogen-activated protein kinases p38 and ERK 1/2 mediate the wall stress-induced activation of GATA-4 binding in adult heart. J. Biol. Chem. 279(23): 24852- 24860. doi:10.1074/jbc.M314317200. PMID:15051723.
48. Thuerauf, D.J., and Glembotski, C.C. 1997. Differential effects of protein kinase C, Ras, and Raf-1 kinase on the induction of the cardiac B-type natriuretic peptide gene through a critical promoter-proximal M-CAT element. J. Biol. Chem. 272(11): 7464-7472. doi:10.1074/jbc.272.11.7464. PMID:9054448.
49. Tokola, H., Salo, K., Vuolteenaho, O., and Ruskoaho, H. 1994. Basal and acidic fibroblast growth factor-induced atrial natriuretic peptide gene expression and secretion is inhibited by staurospor-ine. Eur. J. Pharmacol. 267(2): 195-206. doi:10.1016/0922-4106 (94)90171-6. PMID:7519562.
50. Tokola, H., Hautala, N., Marttila, M., Magga, J., Pikkarainen, S., Kerkela, R., et al. 2001. Mechanical load-induced alterations in B-type natriuretic peptide gene expression. Can. J. Physiol. Pharmacol. 79(8): 646-653. doi:10.1139/y01-031. PMID:11558673.
51. Ueyama, T., Zhu, C., Valenzuela, Y.M., Suzow, J.G., and Stewart, A.F. 2000. Identification of the functional domain in the transcription factor RTEF-1 that mediates alpha 1-adrenergic signaling in hypertrophied cardiac myocytes. J. Biol. Chem. 275(23): 17476- 17480. doi:10.1074/jbc.M001970200. PMID:10764782.
52. Wright, C.E., Bodell, P.W., Haddad, F., Qin, A.X., and Baldwin, K.M. 2001. In vivo regulation of the beta-myosin heavy chain gene in hypertensive rodent heart. Am. J. Physiol. Cell Physiol. 280(5): C1262-C1276. PMID:11287340.
53. Xiao, J.H., Davidson, I., Matthes, H., Garnier, J.M., and Chambon, P. 1991. Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell, 65(4): 551-568. doi:10.1016/ 0092-8674(91)90088-G. PMID:1851669.
54. Yoshida, T. 2008. MCAT elements and the TEF-1 family of transcription factors in muscle development and disease. Arter-ioscler. Thromb. Vasc. Biol. 28(1): 8-17. doi:10.1161/ ATVBAHA.107.155788. PMID:17962623.